Skip to main content
UK clinical trials - updated daily from ClinicalTrials.gov
TrialConnect
← Back to Search
Looking for participantsN/A

Clinical Validity of the DANU Sports System for Gait and Balance Assessment in Parkinson's Disease

Sponsor: Northumbria University

NCT ID: NCT07281794

View on ClinicalTrials.gov ↗

At a glance

What the study gets you
Health checks and monitoring — no treatment given
Type of study
Observational (no treatment given)
Time in hospital
In-person visits at study sites — visit count not specified by the sponsor
Drug or intervention
Not specified by the sponsor
How long the study runs
Study runs about 25 months (dates as stated)
About the drug or intervention
Not specified by the sponsor
Patient visit burden
Not specified by the sponsor
Type of study
Observing health over time
Ages
50 Years and over
Who
All
Number of participants
60
Started
2025-08-08
Last checked
2025-09

Plain English Summary

What is this study?

  • • Testing a new treatment for parkinson disease (pd)
  • • Clinical study - 60 participants
  • • This observational study aims to explore the use of the DANU Smart Socks for gait and balance assessment in people with Parkinson's (PwP)

Who can take part?

  • • Ages 50 Years and over
  • • Diagnosed with parkinson disease (pd)

Where?

  • • Newcastle upon Tyne - Northumbria University
  • • Newcastle upon Tyne - Northumbria University

This is a simplified summary. Always discuss with your doctor before making any decisions.

About This Trial

This observational study aims to explore the use of the DANU Smart Socks for gait and balance assessment in people with Parkinson's (PwP). The study will compare walking and balance outcomes produced by DANU from people with Parkinson's (PwP) and a group of healthy individuals of similar age. The project aims to investigate if the gait and balance data collected are linked to measures of Parkinson's symptoms such as disease progression and cognitive abilities. Gait and balance outcomes will be obtained through one observational laboratory visit.

More detail

Methods: Institutional ethics have been obtained (Project ID: 8543). Utilising an observational design, participants will be asked to attend one visit to Northumbria University, Newcastle Upon Tyne. Visit 1: Participants will complete a series of clinical and cognitive measures including the Movement Disorders Society's-Unified Parkinson's Disease Rating Scale, Montreal Cognitive Assessment, Freezing of Gait Questionnaire and Falls Efficacy Scale to act as descriptive measures. Following this, the investigators will conduct a concurrent data collection throughout a battery of motor tasks. The DANU system will be used alongside APDM Mobility Lab throughout the full duration of data collection. Mobility assessments include a 2-Minute Walk Test, 3 walkway trials, a Timed Up and Go and a series of 2-Minute Balance tasks.

Parkinson Disease (PD)Healthy (Controls)

How this trial compares with your answers

Answer 2 more questions to improve match

What we know so far

Condition· Matched your search
Age· Tell us your age for better matching
Gender· Tell us your sex for better matching

Still need:

  • • Tell us your age for better matching
  • • Tell us your sex for better matching

Preliminary match based on your answers. Full eligibility requires on-site assessment including medical history, physical exam, and lab tests. This does not guarantee enrolment.

Eligibility at a Glance

Key info

  • Age: 50 Years and over
  • Who can join: All genders

What the study is looking for

  • ✓Clinical diagnosis of Parkinson's by a movement disorder specialist according to UK brain bank criteria.
  • ✓PD stages I-III (Hoehn and Yahr Rating Scale)
  • ✓Able to attend Northumbria University, Newcastle Upon Tyne for study visits.
  • ✓Able to walk and stand unassisted for a minimum of 2-minutes.
  • ✓Aged 50 years old or over

Who cannot take part

  • ✗History of neurological disorders other than PD (e.g., Huntington's disease, stroke, traumatic brain injury,...
  • ✗Unable to walk or stand unaided.
  • ✗Montreal Cognitive Assessment (MoCA) score \< 21
  • ✗Significant issues unrelated to PD that may affect gait (e.g., musculoskeletal issues, back pain, recent surgery etc.)
  • ✗Healthy Control Inclusion Criteria:
See the full criteria
Parkinson's Group Inclusion Criteria:- Clinical diagnosis of Parkinson's by a movement disorder specialist according to UK brain bank criteria. * PD stages I-III (Hoehn and Yahr Rating Scale) * Able to attend Northumbria University, Newcastle Upon Tyne for study visits. * Able to walk and stand unassisted for a minimum of 2-minutes. * Aged 50 years old or over Parkinson's Group Exclusion Criteria: * History of neurological disorders other than PD (e.g., Huntington's disease, stroke, traumatic brain injury, multiple sclerosis, Alzheimer's disease etc.) * Unable to walk or stand unaided. * Montreal Cognitive Assessment (MoCA) score \< 21 * Significant issues unrelated to PD that may affect gait (e.g., musculoskeletal issues, back pain, recent surgery etc.) Healthy Control Inclusion Criteria: * Ability to attend Northumbria University, Newcastle Upon Tyne for study visits. * Aged 50 years old or over. * Able to walk and stand unassisted for a minimum of 2-minutes. Healthy Control Exclusion Criteria: * History of neurological disorders (e.g. Huntington's disease, stroke, traumatic brain injury, multiple sclerosis, Alzheimer's disease etc.) * Significant issues that may affect walking (e.g., musculoskeletal issues, back pain, recent surgery etc.)

Where Is This Study? (2 UK sites)

Northumbria University

Newcastle upon Tyne, United Kingdom

Recruiting
Site contact (verified)
Rodrigo Vitorio, PhDPrincipal Investigator
Rodrigo Vitorio, PhD01912156078

Northumbria University

Newcastle upon Tyne, United Kingdom

ENROLLING_BY_INVITATION
Hospital R&D contact (matched)

Research and Development

researchanddevelopment@nhct.nhs.uk0191 2934087

How to Get in Touch

Gabriella R Gatti, BSc

Sponsor contact

CONTACT

01912273343 gabriella.gatti@northumbria.ac.uk

Rodrigo Vitorio, PhD

Sponsor contact

CONTACT

01912273343 rodrigo.vitorio@northumbria.ac.uk
Data sourced from ClinicalTrials.gov · Last verified: 2025-09